Table 1—

Age-specific prevalences of known diabetes and antidiabetic medication in men and women in four population surveys, 1984–2001

Survey year
1984/1985
1989/1990
1994/1995
1999/2001
Age for men (years)
    25–342/4640.41/4700.20/4442/4090.5
    35–446/4851.2 (0.3–2.2)4/4620.92/4570.44/4191.0
    45–5411/5392.0 (0.9–3.2)29/5205.6 (3.6–7.6)20/4824.2 (2.4–5.9)10/4182.4 (0.9–3.9)
    55–6441/5357.7 (5.4–9.9)45/5108.8 (6.4–11.3)44/5318.3 (5.9–10.6)30/4436.8 (4.4–9.1)
    65–7454/52010.4 (7.8–13.0)54/49111.0 (8.2–13.8)43/39710.8 (7.8–13.9)
    25–64*60/20232.7 (2.0–3.4)79/19623.6 (2.8–4.4)66/19143.0 (2.3–3.7)46/16892.5 (1.8–3.2)
    25–74*133/24824.6 (3.8–5.3)120/24054.1 (3.4–4.8)89/20863.7 (2.9–4.4)
Age for Women (years)
    25–341/4630.20/4761/4620.22/4390.5
    35–443/5230.62/4860.45/5141.08/4641.7 (0.5–2.9)
    45–547/5151.4 (0.4–2.4)13/5392.4 (1.1–3.7)16/5103.1 (1.6–4.7)11/4572.4 (1.0–3.8)
    55–6433/4986.6 (4.4–8.8)35/5037.0 (4.7–9.2)32/5166.2 (4.1–8.3)30/4386.9 (4.5–9.2)
    65–7452/45411.5 (8.5–14.4)49/44910.9 (8.0–13.8)30/3718.1 (5.3–10.9)
    25–64*44/19992.0 (1.5–2.6)50/20042.3 (1.7–2.9)54/20022.5 (1.8–3.1)51/17982.7 (2.0–3.5)
    25–74*102/24583.6 (2.9–4.2)103/24513.7 (3.0–4.4)81/21693.5 (2.8–4.2)
Antidiabetic treatment
    Insulin13 (12.5)23 (9.8)24 (10.8)28 (16.6)
    Sulfonylurea44 (42.3)108 (46.0)59 (26.5)26 (15.4)
    Biguanides and/or acarbose1 (0.4)22 (9.9)35 (20.7)
    Insulin and sulfonylurea18 (7.7)10 (4.5)7 (4.1)
    Insulin and biguanides /acarbose1 (0.4)4 (1.8)8 (4.7)
    Sulfonylurea and biguanides/acarbose2 (0.9)26 (11.7)30 (17.8)
    Insulin, sulfonylurea and biguanides/acarbose8 (3.6)5 (3.0)
    No antidiabetic drug (diet only)47 (45.2)82 (34.9)70 (31.4)30 (17.8)
  • Data are percent, % (95% CI), or n (%).

  • *

    * Age standardizing according to the age distribution of the population of the Federal Republic of Germany on 31 December 2000.